206 related articles for article (PubMed ID: 33302291)
1. Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation.
Clayton NP; Khan-Malek RC; Dangler CA; Zhang D; Ascah A; Gains M; Gardner B; Mockbee C; Keutzer JM; McManus J; Authier S
Radiat Res; 2021 Feb; 195(2):191-199. PubMed ID: 33302291
[TBL] [Abstract][Full Text] [Related]
2. Sargramostim in acute radiation syndrome.
Lazarus HM; McManus J; Gale RP
Expert Opin Biol Ther; 2022 Nov; 22(11):1345-1352. PubMed ID: 36325797
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model.
Zhong Y; Pouliot M; Downey AM; Mockbee C; Roychowdhury D; Wierzbicki W; Authier S
Int J Radiat Biol; 2021; 97(sup1):S100-S116. PubMed ID: 32960660
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.
Neelis KJ; Hartong SC; Egeland T; Thomas GR; Eaton DL; Wagemaker G
Blood; 1997 Oct; 90(7):2565-73. PubMed ID: 9326222
[TBL] [Abstract][Full Text] [Related]
5. Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation Alone and Followed by Wound Trauma.
Kiang JG; Zhai M; Bolduc DL; Smith JT; Anderson MN; Ho C; Lin B; Jiang S
Radiat Res; 2017 Nov; 188(5):476-490. PubMed ID: 28850300
[TBL] [Abstract][Full Text] [Related]
6. Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Hussein AM; Ross M; Vredenburgh J; Meisenberg B; Hars V; Gilbert C; Petros WP; Coniglio D; Kurtzberg J; Rubin P
Eur J Haematol; 1995 May; 54(5):281-7. PubMed ID: 7781752
[TBL] [Abstract][Full Text] [Related]
7. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
Scheding S; Media JE; KuKuruga MA; Nakeff A
Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
[TBL] [Abstract][Full Text] [Related]
8. Use of molecularly-cloned haematopoietic growth factors in persons exposed to acute high-dose, high-dose rate whole-body ionizing radiations.
Gale RP; Armitage JO
Blood Rev; 2021 Jan; 45():100690. PubMed ID: 32273121
[TBL] [Abstract][Full Text] [Related]
9. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
[TBL] [Abstract][Full Text] [Related]
10. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS Mortality and Hematopoietic Recovery in Nonhuman Primates After 10-Gy Irradiation With 2.5% Bone Marrow Sparing.
Farese AM; Bennett AW; Gibbs AM; Hankey KG; Prado K; Jackson W; MacVittie TJ
Health Phys; 2019 Mar; 116(3):339-353. PubMed ID: 30281533
[TBL] [Abstract][Full Text] [Related]
12. Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures.
Lazarus HM; Armitage JO; Gale RP
J Radiol Prot; 2021 Nov; 41(4):. PubMed ID: 34134098
[TBL] [Abstract][Full Text] [Related]
13. Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.
Hankey KG; Farese AM; Blaauw EC; Gibbs AM; Smith CP; Katz BP; Tong Y; Prado KL; MacVittie TJ
Radiat Res; 2015 Jun; 183(6):643-55. PubMed ID: 26035709
[TBL] [Abstract][Full Text] [Related]
14. Single-Dose Administration of Recombinant Human Thrombopoietin Mitigates Total Body Irradiation-Induced Hematopoietic System Injury in Mice and Nonhuman Primates.
Xing S; Shen X; Yang JK; Wang XR; Ou HL; Zhang XW; Xiong GL; Shan YJ; Cong YW; Luo QL; Yu ZY
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1357-1367. PubMed ID: 32758640
[TBL] [Abstract][Full Text] [Related]
15. Overview of use of G-CSF and GM-CSF in the treatment of acute radiation injury.
Reeves G
Health Phys; 2014 Jun; 106(6):699-703. PubMed ID: 24776902
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J
Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor.
MacVittie TJ; Farese AM; Herodin F; Grab LB; Baum CM; McKearn JP
Blood; 1996 May; 87(10):4129-35. PubMed ID: 8639770
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic Effect of Combined Cytokines on Nonhuman Primate Model of Severe Haemopoietic Acute Radiation Sickness].
Ma YC; Li M; Xing S; Xiong GL; Shen X; Chen Q; Cong YW; Wang JX; Zhu NK; Yu ZY; Zhang XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):573-9. PubMed ID: 27151032
[TBL] [Abstract][Full Text] [Related]
19. Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Lazarus HM; Ragsdale CE; Gale RP; Lyman GH
Front Immunol; 2021; 12():706186. PubMed ID: 34484202
[TBL] [Abstract][Full Text] [Related]
20. Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
Hussein AM; Ross M; Vredenburgh J; Meisenberg B; Hars V; Gilbert C; Petros WP; Coniglio D; Kurtzberg J; Rubin P
Eur J Haematol; 1995 Nov; 55(5):348-56. PubMed ID: 7493686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
